Company

Novartis

Official Name: Novartis AG

Headquarters: Basel, Switzerland

Founded: March 1996

Employees: 104,323

show_chart SIX: NOVN

Market Cap

CHF188.95 Billion

CHF as of April 1, 2022

US$204.13 Billion

history Market Cap History

Novartis market capitalization evolution

Evolution of Novartis AG market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

history Market Cap History of Novartis AG

Detailed Description

Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatology, respiratory, cardiovascular, renal, and metabolism medicine products. The Sandoz segment develops, manufactures, and markets finished dosage form medicines; active ingredients and finished dosage forms of small molecule pharmaceuticals to third parties; and retail generics and anti-infectives. It also provides active pharmaceutical ingredients and intermediates primarily antibiotics; protein- or other biotechnology-based products, including biosimilars; and biotechnology manufacturing services. Novartis AG has a license and collaboration agreement with Alnylam Pharmaceuticals to develop, manufacture, and commercialize inclisiran; and a clinical collaboration with Kura Oncology, Inc. to evaluate the combination of Tipifarnib and Alpelisib in patients with head and neck squamous cell carcinoma. The company was incorporated in 1996 and is headquartered in Basel, Switzerland.

Wikipedia Introduction

Novartis International AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. It is one of the largest pharmaceutical companies in the world. Novartis manufactures the drugs clozapine (Clozaril), diclofenac (Voltaren; sold to GlaxoSmithKline in 2015 deal), carbamazepine (Tegretol), valsartan (Diovan), imatinib mesylate (Gleevec/Glivec), cyclosporine (Neoral/Sandimmune), letrozole (Femara), methylphenidate (Ritalin; production ceased 2020), terbinafine (Lamisil), deferasirox (Exjade), and others. In March 1996, the companies Ciba-Geigy and Sandoz merged to form Novartis; the pharmaceutical and agrochemical divisions of both companies formed Novartis as an independent entity. Other Ciba-Geigy and Sandoz businesses were sold, or, like Ciba Specialty Chemicals, spun off as independent companies. The Sandoz brand disappeared for three years, but was revived in 2003 when Novartis consolidated its generic drugs businesses into a single subsidiary and named it Sandoz. Novartis divested its agrochemical and genetically modified crops business in 2000 with the spinout of Syngenta in partnership with AstraZeneca, which also divested its agrochemical business. Novartis is a full member of the European Federation of Pharmaceutical Industries and Associations (EFPIA), the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), and the Pharmaceutical Research and Manufacturers of America (PhRMA).

Source: Wikipedia, retrieved on March 31, 2022, 9:02 p.m.

Best-Selling Downloads

S&P 500 Companies Excel Download $29.90
Russell 3000 Companies Excel Download $99.90
580 Unicorn Startup Companies – Excel Spreadsheet $29.90
FTSE 350 Companies Excel Download $24.90
Top 1300 UK Companies [FTSE All-Share + FTSE AIM All-Share] – Excel Download $59.90
TSX Composite Companies Excel Download $19.90

Save tens of hours in 2 minutes!

Product & Services

Pharmaceuticals, generic drugs, over-the-counter drugs, vaccines, diagnostics, contact lenses, animal health (list...)

Key People

Founder(s): Johann Rudolf Alexander Clavel

Vasant Narasimhan (CEO)

Financials

Revenue: US$49.89 billion (2020)

Operating income: US$10.15 billion (2020)

Net income: US$8.07 billion (2020)


Total assets: US$132.06 billion (2020)

Total equity: US$56.67 billion (2020)

Stocks & Indices

Novartis AG has the following listings and related stock indices.


Stock: SIX: NOVN

Stock: NYSE: NVS

Stock: BCBA: NVS

Stock: Bovespa: N1VS34

Stock: FSX: NOTA

Stock: OTC: NVSEF

Stock: SIX: NOVNEE

Details

Headquarters:

Lichtstrasse 35

Basel, 4056

Switzerland

Phone: 41 61 324 1111

Fax: 41 61 324 8001